Titre : Enzymes multifonctionnelles

Enzymes multifonctionnelles : Questions médicales fréquentes

Termes MeSH sélectionnés :

Cluster Analysis
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Enzymes multifonctionnelles : Questions médicales les plus fréquentes", "headline": "Enzymes multifonctionnelles : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Enzymes multifonctionnelles : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-31", "dateModified": "2025-04-25", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Enzymes multifonctionnelles" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Enzymes", "url": "https://questionsmedicales.fr/mesh/D004798", "about": { "@type": "MedicalCondition", "name": "Enzymes", "code": { "@type": "MedicalCode", "code": "D004798", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Acetyl-coA carboxylase", "alternateName": "Acetyl-CoA Carboxylase", "url": "https://questionsmedicales.fr/mesh/D000103", "about": { "@type": "MedicalCondition", "name": "Acetyl-coA carboxylase", "code": { "@type": "MedicalCode", "code": "D000103", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.641.249" } } }, { "@type": "MedicalWebPage", "name": "Lactase-phlorizin hydrolase", "alternateName": "Lactase-Phlorizin Hydrolase", "url": "https://questionsmedicales.fr/mesh/D010694", "about": { "@type": "MedicalCondition", "name": "Lactase-phlorizin hydrolase", "code": { "@type": "MedicalCode", "code": "D010694", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.641.761" } } } ], "about": { "@type": "MedicalCondition", "name": "Enzymes multifonctionnelles", "alternateName": "Multifunctional Enzymes", "code": { "@type": "MedicalCode", "code": "D064251", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Yi Zhang", "url": "https://questionsmedicales.fr/author/Yi%20Zhang", "affiliation": { "@type": "Organization", "name": "Beijing Key Lab of Bioprocess, Beijing University of Chemical Technology, Beijing, 100029, PR China." } }, { "@type": "Person", "name": "Ruiping Zhang", "url": "https://questionsmedicales.fr/author/Ruiping%20Zhang", "affiliation": { "@type": "Organization", "name": "Department of Radiology, First hospital of Shanxi Medical University, Taiyuan, 030001, China. gzgtg@163.com." } }, { "@type": "Person", "name": "M Shelomi", "url": "https://questionsmedicales.fr/author/M%20Shelomi", "affiliation": { "@type": "Organization", "name": "Department of Entomology, National Taiwan University, Taipei, Taiwan." } }, { "@type": "Person", "name": "B Wipfler", "url": "https://questionsmedicales.fr/author/B%20Wipfler", "affiliation": { "@type": "Organization", "name": "Zoologisches Forschungsmuseum Alexander Koenig, Bonn, Germany." } }, { "@type": "Person", "name": "X Zhou", "url": "https://questionsmedicales.fr/author/X%20Zhou", "affiliation": { "@type": "Organization", "name": "Department of Entomology, China Agricultural University, Beijing, China." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Structures of multivariables affecting literacy: Cluster analysis.", "datePublished": "2024-10-29", "url": "https://questionsmedicales.fr/article/39471203", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pone.0310114" } }, { "@type": "ScholarlyArticle", "name": "Mapping, clustering, and analysis of research in psychiatric genomics.", "datePublished": "2022-10-21", "url": "https://questionsmedicales.fr/article/36302202", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/YPG.0000000000000325" } }, { "@type": "ScholarlyArticle", "name": "CAGECAT: The CompArative GEne Cluster Analysis Toolbox for rapid search and visualisation of homologous gene clusters.", "datePublished": "2023-05-03", "url": "https://questionsmedicales.fr/article/37131131", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12859-023-05311-2" } }, { "@type": "ScholarlyArticle", "name": "A topographical analysis of encephalocele locations: generation of a standardised atlas and cluster analysis.", "datePublished": "2023-03-10", "url": "https://questionsmedicales.fr/article/36897404", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00381-023-05883-7" } }, { "@type": "ScholarlyArticle", "name": "Phenotyping of atrial fibrillation with cluster analysis and external validation.", "datePublished": "2023-11-10", "url": "https://questionsmedicales.fr/article/37263768", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1136/heartjnl-2023-322447" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Enzymes et coenzymes", "item": "https://questionsmedicales.fr/mesh/D045762" }, { "@type": "ListItem", "position": 3, "name": "Enzymes", "item": "https://questionsmedicales.fr/mesh/D004798" }, { "@type": "ListItem", "position": 4, "name": "Enzymes multifonctionnelles", "item": "https://questionsmedicales.fr/mesh/D064251" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Enzymes multifonctionnelles - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Enzymes multifonctionnelles", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-09", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Enzymes multifonctionnelles", "description": "Comment diagnostiquer une déficience en enzymes multifonctionnelles ?\nQuels tests sont utilisés pour évaluer l'activité enzymatique ?\nLes biopsies sont-elles nécessaires pour le diagnostic ?\nQuels symptômes peuvent indiquer un problème enzymatique ?\nPeut-on utiliser l'imagerie pour diagnostiquer des troubles enzymatiques ?", "url": "https://questionsmedicales.fr/mesh/D064251?mesh_terms=Cluster+Analysis&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Enzymes multifonctionnelles", "description": "Quels sont les symptômes d'une déficience enzymatique ?\nLes symptômes varient-ils selon l'enzyme affectée ?\nY a-t-il des symptômes neurologiques associés ?\nLes symptômes peuvent-ils apparaître à tout âge ?\nComment les symptômes évoluent-ils dans le temps ?", "url": "https://questionsmedicales.fr/mesh/D064251?mesh_terms=Cluster+Analysis&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Enzymes multifonctionnelles", "description": "Peut-on prévenir les déficiences enzymatiques ?\nLe dépistage néonatal est-il utile ?\nLes conseils génétiques sont-ils recommandés ?\nL'alimentation peut-elle prévenir des troubles enzymatiques ?\nY a-t-il des vaccins pour prévenir ces déficiences ?", "url": "https://questionsmedicales.fr/mesh/D064251?mesh_terms=Cluster+Analysis&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Enzymes multifonctionnelles", "description": "Quels traitements existent pour les déficiences enzymatiques ?\nLes thérapies géniques sont-elles efficaces ?\nComment les régimes alimentaires aident-ils ?\nLes médicaments peuvent-ils aider à traiter ces déficiences ?\nY a-t-il des traitements expérimentaux disponibles ?", "url": "https://questionsmedicales.fr/mesh/D064251?mesh_terms=Cluster+Analysis&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Enzymes multifonctionnelles", "description": "Quelles complications peuvent survenir avec des déficiences enzymatiques ?\nLes complications sont-elles réversibles ?\nComment les complications affectent-elles la qualité de vie ?\nY a-t-il des risques de cancer associés ?\nLes complications peuvent-elles être prévenues ?", "url": "https://questionsmedicales.fr/mesh/D064251?mesh_terms=Cluster+Analysis&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Enzymes multifonctionnelles", "description": "Quels sont les facteurs de risque pour les déficiences enzymatiques ?\nLes facteurs environnementaux jouent-ils un rôle ?\nL'âge est-il un facteur de risque ?\nLes maladies concomitantes augmentent-elles le risque ?\nLes habitudes alimentaires influencent-elles le risque ?", "url": "https://questionsmedicales.fr/mesh/D064251?mesh_terms=Cluster+Analysis&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une déficience en enzymes multifonctionnelles ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sanguins et des analyses génétiques peuvent identifier des déficiences enzymatiques." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer l'activité enzymatique ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests enzymatiques spécifiques mesurent l'activité des enzymes dans des échantillons biologiques." } }, { "@type": "Question", "name": "Les biopsies sont-elles nécessaires pour le diagnostic ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Parfois, des biopsies tissulaires sont nécessaires pour évaluer l'activité enzymatique in situ." } }, { "@type": "Question", "name": "Quels symptômes peuvent indiquer un problème enzymatique ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme la fatigue, des douleurs abdominales ou des troubles métaboliques peuvent survenir." } }, { "@type": "Question", "name": "Peut-on utiliser l'imagerie pour diagnostiquer des troubles enzymatiques ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'imagerie peut aider à évaluer des complications, mais n'est pas spécifique pour les enzymes." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une déficience enzymatique ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent fatigue, douleurs abdominales, et troubles digestifs variés." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon l'enzyme affectée ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes dépendent de l'enzyme spécifique et de son rôle dans le métabolisme." } }, { "@type": "Question", "name": "Y a-t-il des symptômes neurologiques associés ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Certaines déficiences enzymatiques peuvent entraîner des symptômes neurologiques comme des convulsions." } }, { "@type": "Question", "name": "Les symptômes peuvent-ils apparaître à tout âge ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent se manifester à tout âge, selon la nature de la déficience." } }, { "@type": "Question", "name": "Comment les symptômes évoluent-ils dans le temps ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes peuvent s'aggraver avec le temps si la déficience n'est pas traitée." } }, { "@type": "Question", "name": "Peut-on prévenir les déficiences enzymatiques ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Certaines déficiences peuvent être évitées par des conseils génétiques et un dépistage précoce." } }, { "@type": "Question", "name": "Le dépistage néonatal est-il utile ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le dépistage néonatal permet d'identifier certaines déficiences enzymatiques précocement." } }, { "@type": "Question", "name": "Les conseils génétiques sont-ils recommandés ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les conseils génétiques sont recommandés pour les familles à risque de maladies enzymatiques." } }, { "@type": "Question", "name": "L'alimentation peut-elle prévenir des troubles enzymatiques ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée peut aider à réduire le risque de certains troubles métaboliques." } }, { "@type": "Question", "name": "Y a-t-il des vaccins pour prévenir ces déficiences ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Actuellement, il n'existe pas de vaccins spécifiques pour prévenir les déficiences enzymatiques." } }, { "@type": "Question", "name": "Quels traitements existent pour les déficiences enzymatiques ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent des suppléments enzymatiques, des régimes alimentaires spécifiques et des thérapies géniques." } }, { "@type": "Question", "name": "Les thérapies géniques sont-elles efficaces ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Les thérapies géniques montrent des résultats prometteurs pour certaines déficiences enzymatiques." } }, { "@type": "Question", "name": "Comment les régimes alimentaires aident-ils ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des régimes spécifiques peuvent réduire les symptômes en limitant les substrats non métabolisés." } }, { "@type": "Question", "name": "Les médicaments peuvent-ils aider à traiter ces déficiences ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Certains médicaments peuvent aider à gérer les symptômes, mais ne corrigent pas la déficience." } }, { "@type": "Question", "name": "Y a-t-il des traitements expérimentaux disponibles ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des traitements expérimentaux, comme des thérapies ciblées, sont en cours d'évaluation dans des essais cliniques." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec des déficiences enzymatiques ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des troubles métaboliques graves, des dommages organiques et des crises aiguës." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être réversibles avec un traitement précoce, d'autres non." } }, { "@type": "Question", "name": "Comment les complications affectent-elles la qualité de vie ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Les complications peuvent gravement affecter la qualité de vie en limitant les activités quotidiennes." } }, { "@type": "Question", "name": "Y a-t-il des risques de cancer associés ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Certaines déficiences enzymatiques peuvent augmenter le risque de développer certains cancers." } }, { "@type": "Question", "name": "Les complications peuvent-elles être prévenues ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Une gestion appropriée des symptômes et un suivi régulier peuvent aider à prévenir certaines complications." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque pour les déficiences enzymatiques ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent des antécédents familiaux, des mutations génétiques et des régimes alimentaires inappropriés." } }, { "@type": "Question", "name": "Les facteurs environnementaux jouent-ils un rôle ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains facteurs environnementaux peuvent influencer l'expression des gènes enzymatiques." } }, { "@type": "Question", "name": "L'âge est-il un facteur de risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "L'âge peut influencer la gravité des symptômes, mais les déficiences peuvent survenir à tout âge." } }, { "@type": "Question", "name": "Les maladies concomitantes augmentent-elles le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines maladies peuvent exacerber les déficiences enzymatiques et leurs symptômes." } }, { "@type": "Question", "name": "Les habitudes alimentaires influencent-elles le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Des habitudes alimentaires déséquilibrées peuvent augmenter le risque de troubles enzymatiques." } } ] } ] }

Sources (10000 au total)

Mapping, clustering, and analysis of research in psychiatric genomics.

The distribution pattern and knowledge structure of psychiatric genomics were surveyed based on literature dealing with both psychiatry and genomics/genetics. Coword analysis and bibliographic couplin... The data were analyzed using coword analysis and clustering methods using Sci2 and VOSviewer.... Analysis of ~3800 records showed that psychiatric genomics is, as expectedly, covered largely under biomedical subjects with a visible interest in other disciplines such as humanities and ethics. A co... 'Schizophrenia', 'depression', 'pharmacogenomics', and 'immunopathogenesis' were the research topics of overarching interest. 'Gut-brain axis' and 'gene-environment interaction' were the emerging topi...

CAGECAT: The CompArative GEne Cluster Analysis Toolbox for rapid search and visualisation of homologous gene clusters.

Co-localized sets of genes that encode specialized functions are common across microbial genomes and occur in genomes of larger eukaryotes as well. Important examples include Biosynthetic Gene Cluster... The comparative gene cluster analysis toolbox (CAGECAT) is a rapid and user-friendly platform to mitigate difficulties in comparative analysis of whole gene clusters. The software provides homology se... Overall, CAGECAT is an extensible software that can be interfaced via a standard web-browser for whole region homology searches and comparison on continually updated genomes from NCBI. The public web ...

A topographical analysis of encephalocele locations: generation of a standardised atlas and cluster analysis.

Encephaloceles are considered to result from defects in the developing skull through which meninges, and potentially brain tissue, herniate. The pathological mechanism underlying this process is incom... Patients diagnosed with cranial encephaloceles or meningoceles were identified from a prospectively maintained database between 1984 and 2021. Images were transformed to atlas space using non-linear r... Of the 124 patients identified, 55 had volumetric imaging in the form of MRI (48/55) or CT (7/55) that could be used for atlas generation. Median encephalocele volume was 14,704 (IQR 3655-86,746) mm... This analysis revealed three predominant clusters for the location of encephaloceles, with the parieto-occipital junction being the most common. The stereotypic location of encephaloceles into anatomi...

Phenotyping of atrial fibrillation with cluster analysis and external validation.

Atrial fibrillation (AF) is a heterogeneous condition. We performed a cluster analysis in a cohort of patients with AF and assessed the prognostic implication of the identified cluster phenotypes.... We used two multicentre, prospective, observational registries of AF: the SAKURA AF registry (Real World Survey of Atrial Fibrillation Patients Treated with Warfarin and Non-vitamin K Antagonist Oral ... The analysis subclassified derivation cohort patients into five clusters. Cluster 1 (n=414, 13.6%) was characterised by younger men with a low prevalence of comorbidities; cluster 2 (n=1003, 32.8%) by... Machine learning-based cluster analysis identified five different phenotypes of AF with unique clinical characteristics and different clinical outcomes. The use of these phenotypes may help identify h...

Clinical phenotypes of chronic cough categorised by cluster analysis.

Chronic cough is a heterogeneous disease with various aetiologies that are difficult to determine. Our study aimed to categorise the phenotypes of chronic cough.... Adult patients with chronic cough were assessed based on the characteristics and severity of their cough using the COugh Assessment Test (COAT) and the Korean version of the Leicester Cough Questionna... In total, 255 participants were included in the analysis. Based on the correlation network, age, score for each item, and total COAT score were selected for the cluster analysis. Four clusters were id... Cluster analysis of age, score for each item, and total COAT score identified 4 distinct phenotypes of chronic cough with significant differences in the aetiologies. Subgrouping patients with chronic ...

Heterogeneity of asthma with nasal polyposis phenotypes: A cluster analysis.

Chronic rhinosinusitis with nasal polyposis (CRSwNP) affects a significant number of asthmatic patients and is notably associated with a more difficult-to-control asthma and marked inflammation. We ne... The aim of this study is to identify and characterize subphenotypes of asthma patients with CRSwNP using clinical, physiological and inflammatory variables.... K-means cluster analysis was performed on 17 clinical, physiological, and inflammatory variables from 1263 patients of all asthma severity and on a subpopulation of patients with asthma and CRSwNP. St... On the overall population, three groups were identified. Cluster T1 (n = 708) are young, have a short asthma duration and a low prevalence of CRSwNP. Cluster T2 (n = 263) have the longest asthma durat... Despite coexistence of asthma and CRSwNP, not all patients have the same evolution of their asthma. Different phenotypes of asthma with CRSwNP can be identified and exploration of the characteristics ...